These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 32122925)
1. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia. Anande G; Deshpande NP; Mareschal S; Batcha AMN; Hampton HR; Herold T; Lehmann S; Wilkins MR; Wong JWH; Unnikrishnan A; Pimanda JE Clin Cancer Res; 2020 Jul; 26(14):3597-3607. PubMed ID: 32122925 [TBL] [Abstract][Full Text] [Related]
2. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia. Jin P; Tan Y; Zhang W; Li J; Wang K Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835 [TBL] [Abstract][Full Text] [Related]
3. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia. Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187 [TBL] [Abstract][Full Text] [Related]
4. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets. Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058 [TBL] [Abstract][Full Text] [Related]
5. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia. Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135 [TBL] [Abstract][Full Text] [Related]
6. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia. Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia. Yang YT; Yao CY; Chiu PJ; Kao CJ; Hou HA; Lin CC; Chou WC; Tien HF Am J Hematol; 2023 May; 98(5):784-793. PubMed ID: 36855936 [TBL] [Abstract][Full Text] [Related]
9. Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia. Rivera OD; Mallory MJ; Quesnel-Vallières M; Chatrikhi R; Schultz DC; Carroll M; Barash Y; Cherry S; Lynch KW Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876749 [TBL] [Abstract][Full Text] [Related]
10. RNA-Seq profiling reveals aberrant RNA splicing in patient with adult acute myeloid leukemia during treatment. Li XY; Yao X; Li SN; Suo AL; Ruan ZP; Liang X; Kong Y; Zhang WG; Yao Y Eur Rev Med Pharmacol Sci; 2014; 18(9):1426-33. PubMed ID: 24867525 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Characterization of the Prognosis Value of Alternative Splicing Events in Acute Myeloid Leukemia. Chen XX; Zhu JH; Li ZP; Xiao HT; Zhou H DNA Cell Biol; 2020 Jul; 39(7):1243-1255. PubMed ID: 32543226 [TBL] [Abstract][Full Text] [Related]
12. Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing. Dolnik A; Engelmann JC; Scharfenberger-Schmeer M; Mauch J; Kelkenberg-Schade S; Haldemann B; Fries T; Krönke J; Kühn MW; Paschka P; Kayser S; Wolf S; Gaidzik VI; Schlenk RF; Rücker FG; Döhner H; Lottaz C; Döhner K; Bullinger L Blood; 2012 Nov; 120(18):e83-92. PubMed ID: 22976956 [TBL] [Abstract][Full Text] [Related]
13. Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. van der Werf I; Wojtuszkiewicz A; Meggendorfer M; Hutter S; Baer C; Heymans M; Valk PJM; Kern W; Haferlach C; Janssen JJWM; Ossenkoppele GJ; Cloos J; Haferlach T Blood Adv; 2021 Sep; 5(17):3254-3265. PubMed ID: 34448812 [TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia. Liu J; Huang B; Xiao Y; Xiong HM; Li J; Feng DQ; Chen XM; Zhang HB; Wang XZ Onkologie; 2012; 35(6):335-40. PubMed ID: 22722453 [TBL] [Abstract][Full Text] [Related]
15. RNA-Seq analysis identifies aberrant RNA splicing of TRIP12 in acute myeloid leukemia patients at remission. Gao P; Jin Z; Cheng Y; Cao X Tumour Biol; 2014 Oct; 35(10):9585-90. PubMed ID: 24961348 [TBL] [Abstract][Full Text] [Related]
16. Splicing Factor Mutations in Cancer. Bejar R Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388 [TBL] [Abstract][Full Text] [Related]
17. Improving AML Classification Using Splicing Signatures. Bowman TV Clin Cancer Res; 2020 Jul; 26(14):3503-3504. PubMed ID: 32317289 [TBL] [Abstract][Full Text] [Related]
18. Effects of Alternative Splicing Events on Acute Myeloid Leukemia. Chen SL; Dai YJ; Hu F; Wang Y; Li H; Liang Y DNA Cell Biol; 2020 Nov; 39(11):2040-2051. PubMed ID: 32915082 [TBL] [Abstract][Full Text] [Related]
19. Prognostic alternative splicing regulatory network of splicing events in acute myeloid leukemia patients based on SpliceSeq data from 136 cases. Xie ZC; Gao L; Chen G; Ma J; Yang LH; He RQ; Li MW; Cai KT; Li TT; Peng ZG Neoplasma; 2020 May; 67(3):623-635. PubMed ID: 32039631 [TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression. Wu B; Chen X; Pan X; Deng X; Li S; Wang Z; Wang J; Liao D; Xu J; Chen M; Zhao C; Xue Z; Wang Y; Niu T; Lin J; Chen L; Liu Y; Chen C PLoS Biol; 2023 May; 21(5):e3002088. PubMed ID: 37130348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]